These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 28207836

  • 21. Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.
    Xu J, Lin S, Myers RW, Addona G, Berger JP, Campbell B, Chen HS, Chen Z, Eiermann GJ, Elowe NH, Farrer BT, Feng W, Fu Q, Kats-Kagan R, Kavana M, Malkani S, McMasters DR, Mitra K, Pachanski MJ, Tong X, Trujillo ME, Xu L, Zhang B, Zhang F, Zhang R, Parmee ER.
    Bioorg Med Chem Lett; 2017 May 01; 27(9):2069-2073. PubMed ID: 28284804
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus.
    O'Rourke CM, Davis JA, Saltiel AR, Cornicelli JA.
    Metabolism; 1997 Feb 01; 46(2):192-8. PubMed ID: 9030828
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The hepatoselective glucokinase activator PF-04991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic rats.
    Erion DM, Lapworth A, Amor PA, Bai G, Vera NB, Clark RW, Yan Q, Zhu Y, Ross TT, Purkal J, Gorgoglione M, Zhang G, Bonato V, Baker L, Barucci N, D'Aquila T, Robertson A, Aiello RJ, Yan J, Trimmer J, Rolph TP, Pfefferkorn JA.
    PLoS One; 2014 Feb 01; 9(5):e97139. PubMed ID: 24858947
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Small molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humans.
    De Ceuninck F, Kargar C, Ilic C, Caliez A, Rolin JO, Umbdenstock T, Vinson C, Combettes M, de Fanti B, Harley E, Sadlo M, Lefèvre AL, Broux O, Wierzbicki M, Fourquez JM, Perron-Sierra F, Kotschy A, Ktorza A.
    Br J Pharmacol; 2013 Jan 01; 168(2):339-53. PubMed ID: 22925001
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of 1-[4- [2-(4-bromobenzenesulfonamino) ethyl] phenylsulfonyl]-3-(trans-4-methylcyclohexyl)urea (I4), a new synthetic sulfonylurea compound, on glucose metabolism in vivo and in vitro.
    Wu GZ, Hong G, Zhang WP, Zhang HB.
    Arzneimittelforschung; 2009 Jan 01; 59(11):550-6. PubMed ID: 20066963
    [Abstract] [Full Text] [Related]

  • 30. In situ glucose uptake and glucokinase activity of pancreatic islets in diabetic and obese rodents.
    Liang Y, Bonner-Weir S, Wu YJ, Berdanier CD, Berner DK, Efrat S, Matschinsky FM.
    J Clin Invest; 1994 Jun 01; 93(6):2473-81. PubMed ID: 8200983
    [Abstract] [Full Text] [Related]

  • 31. Swertisin rich fraction from Enicostema littorale ameliorates hyperglycemia and hyperlipidemia in high-fat fed diet and low dose streptozotacin induced type 2 diabetes mellitus in rats.
    Mokashi P, Bhatt LK, Khanna A, Pandita N.
    Biomed Pharmacother; 2017 Dec 01; 96():1427-1437. PubMed ID: 29031588
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Des-aspartate-angiotensin I exerts hypoglycemic action via glucose transporter-4 translocation in type 2 diabetic KKAy mice and GK rats.
    Sim MK, Xu XG, Wong YC, Sim SZ, Lee KO.
    Endocrinology; 2007 Dec 01; 148(12):5925-32. PubMed ID: 17823251
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Therapeutic properties of VO(dmpp)2 as assessed by in vitro and in vivo studies in type 2 diabetic GK rats.
    Domingues N, Pelletier J, Ostenson CG, Castro MM.
    J Inorg Biochem; 2014 Feb 01; 131():115-22. PubMed ID: 24333827
    [Abstract] [Full Text] [Related]

  • 38. Hypothalamic arcuate nucleus glucokinase regulates insulin secretion and glucose homeostasis.
    Ma Y, Ratnasabapathy R, Izzi-Engbeaya C, Nguyen-Tu MS, Richardson E, Hussain S, De Backer I, Holton C, Norton M, Carrat G, Schwappach B, Rutter GA, Dhillo WS, Gardiner J.
    Diabetes Obes Metab; 2018 Sep 01; 20(9):2246-2254. PubMed ID: 29748994
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Anti-diabetic effect of methylswertianin and bellidifolin from Swertia punicea Hemsl. and its potential mechanism.
    Tian LY, Bai X, Chen XH, Fang JB, Liu SH, Chen JC.
    Phytomedicine; 2010 Jun 01; 17(7):533-9. PubMed ID: 19962285
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.